Invention Grant
- Patent Title: ECM hydrogel for treating esophageal inflammation
-
Application No.: US16490054Application Date: 2018-03-02
-
Publication No.: US11213545B2Publication Date: 2022-01-04
- Inventor: Stephen Francis Badylak , Juan Diego Naranjo Gutierrez , Lindsey Tamiko Saldin
- Applicant: University of Pittsburgh—Of the Commonwealth System of Higher Education
- Applicant Address: US PA Pittsburgh
- Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
- Current Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
- Current Assignee Address: US PA Pittsburgh
- Agency: Klarquist Sparkman, LLP
- International Application: PCT/US2018/020758 WO 20180302
- International Announcement: WO2018/161028 WO 20180907
- Main IPC: A61K35/12
- IPC: A61K35/12 ; A61P1/04 ; A61K9/06
Abstract:
Methods are disclosed for inhibiting esophageal inflammation in a subject, that include administering to the esophagus of the subject with esophageal inflammation a therapeutically effective amount of an extracellular matrix (ECM) hydrogel. Methods are also disclosed for reducing esophageal stricture. Compositions are disclosed that include an esophageal extracellular matrix (ECM) hydrogel.
Public/Granted literature
- US20200009187A1 ECM HYDROGEL FOR TREATING ESOPHAGEAL INFLAMMATION Public/Granted day:2020-01-09
Information query
